Investors Home  >  Investor Relations

Investor Relations

Ticker: CNAT
4.25 (+ 0.09)
Stock price graph

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.

View all »   RSSRecent Releases

Oct 1, 2015
Conatus Pharmaceuticals Announces Acceptance of Abstracts for AASLD Annual Meeting

Sep 23, 2015
Conatus Announces Top-line Results From Multicenter Phase 2 Portal Hypertension Clinical Trial in Patients With Liver Cirrhosis

View all »Events & Presentations

Sep 24, 2015
Portal Hypertension
Webcast Listen to webcast
PDF View Presentation   1.8 MB   Add to Briefcase

Aug 5, 2015
Conatus Pharmaceuticals Second Quarter 2015 Financial Results
Webcast Listen to webcast